Loren Data's SAM Daily™

FBO DAILY - FEDBIZOPPS ISSUE OF FEBRUARY 25, 2017 FBO #5573
DOCUMENT

65 -- Relenza NDC: 00173-0681-22 - Justification and Approval (J&A)

Notice Date

2/23/2017
 

Notice Type

Justification and Approval (J&A)
 

NAICS

325412 — Pharmaceutical Preparation Manufacturing
 

Contracting Office

Great Lakes Acquisition Center (GLAC);Department of Veteran Affairs;115 S 84th Street, Suite 101; WI 53214-1476
 

ZIP Code

53214-1476
 

Solicitation Number

VA69D17Q0474
 

Archive Date

4/25/2017
 

Point of Contact

Teresa Beers-Wesolowski
 

E-Mail Address

4-4865<br
 

Small Business Set-Aside

N/A
 

Award Number

VA69D-17-C-0092
 

Award Date

2/24/2017
 

Description

The VA Great Lakes Acquisition Center intends to negotiate a sole source contract with GlaxoSmithKline, of Research Triangle Park, NC to provide Relenza NDC 00173-0681-22 to Pharmacy Benefits Management, located at the Hines VAMC. This is a one-time purchase. This procurement is being conducted in accordance FAR 13.106-1(b)(2), only one responsible source and no other supplies or services will satisfy the agency requirements. Contract is firm fixed price and the NAICS Code is 325412. This Notice of Intent is not a request for competitive proposals. No solicitations documents are available and telephone requests will not be honored. However, if a firm believes it can meet the requirements it must furnish information about its products and services, as well as references from other customers who are using these products and service, to the Contracting Officer within seven (7) calendar days from the date of publication of this synopsis. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to comply with the above requirements. Information must be sent to the Contracting Officer, VAMC GLAC, 115 S. 84th Street, Suite 101, Milwaukee WI 53214 or via fax to (414) 844-4888. Responses received will be evaluated however; a determination by the Government not to compete the proposed procurement based upon responses to this notice is solely within the discretion of the Government. If no responses are received, the GLAC will proceed with the sole source negotiation with GlaxoSmithKline.
 

Web Link

FBO.gov Permalink
(https://www.fbo.gov/spg/VA/VAGLHS/VAGLHCS/VA69D17Q0474/listing.html)
 

Document(s)

Justification and Approval (J&A)
 

File Name: VA69D-17-C-0092 VA69D-17-C-0092_1.docx (https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=3293429&FileName=VA69D-17-C-0092-000.docx)

Link: https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=3293429&FileName=VA69D-17-C-0092-000.docx

 

File Name: VA69D-17-C-0092 P03 - Relenza J_A.pdf (https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=3293430&FileName=VA69D-17-C-0092-001.pdf)

Link: https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=3293430&FileName=VA69D-17-C-0092-001.pdf

 

Note: If links are broken, refer to Point of Contact above or contact the FBO Help Desk at 877-472-3779.
 

Record

SN04413210-W 20170225/170223235628-230a3fdc26d5854abd1480f055e1acb2 (fbodaily.com)
 

Source

FedBizOpps Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |